Health, Education & Government Life Sciences & Pharma Pharmaceutical Manufacturing & Labs

Manufacturing Execution Systems

Regulated development and commercialization journeys where clinical, quality, and market access align.

Rockwell Automation Siemens Honeywell Werum IT Solutions
Inside this journey
  1. Customer Discovery

    Capture production pain points, regulatory constraints, stakeholder roles, and measurable success signals.

    Discovery Questions

    Quick Grounding — Tell Me About Today

    • What is your title and primary area of responsibility? Options: VP Manufacturing, Director/Head of Manufacturing IT, Head of Operations, Quality/QA Lead, Site Head/Plant Manager, Other (please specify)
    • Which facility types and product forms do you operate (select all that apply)? Options: Drug substance (API), Drug product (sterile), Drug product (non-sterile), Biologics (DS/DP), Clinical-scale / small-batch CDMO, Commercial-scale CDMO
    • Roughly how many batches does the site run per week or month, and what is a typical batch duration? Options: < 5 batches/month, 5–20 batches/month, 20–100 batches/month, >100 batches/month, Typical batch duration: hours, Typical batch duration: days
    • Describe your current state with electronic systems vs paper batch records—are you fully on paper, partially electronic, or using a legacy MES? Options: Fully paper-based batch records, Hybrid (paper + limited digital), Legacy MES in some lines, Modern MES across site, Piloting EBR in one line
    • How long has your operation relied primarily on paper batch records? Options: Less than 1 year, 1–3 years, 3–7 years, More than 7 years

    If Paper Could Speak, What Would It Confess?

    • What if your paper batch records are the single biggest source of deviations—what incidents or trends make you suspect that?
    • Which types of errors or deviations do paper records most frequently cause at your site? Options: Transcription errors, Missed signatures, Incomplete records, Illegible entries, Version confusion, Other (please describe)
    • On average, how many hours of manual review are required per batch to reconcile, sign-off, and prepare for QA release? Options: < 2 hours, 2–8 hours, 8–24 hours, 24–72 hours, >72 hours
    • Can you share a specific example where a paper-related issue led to a deviation, investigation, or audit observation?
    • How often do transcription or paperwork issues trigger batch holds or delays to release? Options: Almost every batch, Frequently (25–50%), Occasionally (5–25%), Rarely ( <5%)
    • Who ends up doing the bulk of the manual reconciliation work (roles), and how does that impact their day-to-day priorities? Options: Operators, Supervisors/Team leads, Quality/QA staff, Manufacturing engineers, Dedicated batch review team, Other

    Where Real-Time Visibility Should Be — But Isn’t

    • If you had real-time visibility to every running batch, what painful decision would you stop making blind?
    • Which operational decisions are currently delayed because you don’t have timely production data? Options: Hold/release decisions, Resource allocation/line balancing, Material reordering, Deviation triage, Capacity planning, Other
    • How long is your typical data latency from equipment/LIMS/ERP to the person who needs to act? Options: Real-time (seconds/minutes), Near real-time (minutes–hours), End of shift, End of day, Days
    • Which KPIs would you expect to improve with real-time MES visibility? Select top priorities. Options: Reduction in deviations, Faster batch release, Lower review hours, Improved OEE, Fewer inventory surprises, Better compliance posture
    • Tell us about a recent moment when lack of visibility caused either a near-miss or a missed opportunity—what happened and what was the consequence?

    Who's Driving the Ship — Stakeholders, Resistance, and Influence

    • Which individuals or groups would actively support a move to an MES, and who would likely resist it? Options: Executive sponsor (site), Quality/QA, Manufacturing operations, Operators and unions, IT/OT, Regulatory affairs, Finance/Procurement, Other
    • Who is the ultimate decision-maker for technology purchases and validation acceptance at your site? Options: VP Manufacturing, Site Head/Plant Manager, Head of Quality, Head of IT, Central PMO/Procurement, Other
    • How have operators and supervisors reacted to previous digitization efforts—what emotions or objections surfaced and how long did they persist?
    • What level of cross-functional governance would you expect for this project (steering committee, working groups, etc.)? Options: Executive steering committee + working groups, Working groups only, Sponsor + small project team, Informal steering
    • Which groups must be involved in validation and acceptance testing for each release or module? Options: Quality/QA, Manufacturing SMEs, IT/OT, Validation engineers, Regulatory/Compliance, Vendor test lead
    • Has any prior project stalled due to lack of stakeholder alignment? If so, what specifically blocked progress?

    Regulatory Pressure — Are We Playing Defense or Leading?

    • When you think about audits (FDA/EMA), which part of your paper workflows makes you most uneasy? Options: Traceability and genealogy, Signatures and authorizations, Time/date integrity, Deviation documentation, Data reconciliation from instruments, Other
    • Have you had recent regulatory observations tied to batch records, data integrity, or electronic systems? Please summarize frequency and severity. Options: No recent observations, Minor observations, One significant observation in last 3 years, Multiple significant observations
    • What level of validation deliverables do you expect from a vendor (IQ/OQ/PQ scripts, traceability matrix, CSV documentation, URS mapping)? Options: Full IQ/OQ/PQ + CSV packages, IQ/OQ + protocol templates, Standard validation artifacts + site-specific tailoring, Minimal vendor docs; site handles most validation
    • How comfortable are you with a phased validation approach (pilot line validated first, then roll out) versus all-or-nothing validation? Options: Strongly prefer phased, Open to phased with conditions, Prefer full validation at once, Undecided
    • What regulatory documentation or audit evidence would make your QA team confident to sign batch release after go-live?

    Failure Modes & What Keeps You Up at Night

    • Imagine the MES went down mid-batch—what is the single worst operational or regulatory outcome you fear?
    • Which of these failure modes worry you most and why? Options: Data loss or corruption, Integration failures (ERP/LIMS), Incorrect recipe execution, Unauthorized access/data integrity, Operator errors during cutover, Other
    • What existing controls do you have for these risks today (paper backups, manual checklists, duplicate logging)? Options: Paper backups, Secondary manual reconciliation, Operational SOPs, IT backups and change control, None/Ad hoc controls
    • How quickly would you need an incident resolved to avoid serious impact (mean time to recover expectation)? Options: Within minutes, Within an hour, Within a shift, Within 24 hours, Multiple days acceptable
    • Have you performed a risk assessment for digitizing batch records? If yes, what top mitigations were identified?

    Success Signals — How Will We Know We Won?

    • If this MES project is wildly successful, what three measurable outcomes do you want to point to in 12 months? Options: Reduced manual review hours, Lower deviation rate, Faster batch release time, Improved OEE, Complete electronic traceability, Reduced audit findings
    • For each chosen outcome, what numeric target would you set (e.g., reduce review hours by X%, release time from Y to Z)?
    • Who will sign off on those success metrics—operations, QA, IT, or an executive sponsor? Options: Operations, Quality/QA, IT/OT, Site Head, Cross-functional committee
    • What timeline do you consider realistic to see meaningful improvements after go-live (pilot, 6 months, 12 months)? Options: Immediately (pilot), 3 months, 6 months, 12 months, 18+ months
    • Which data sources will be required to measure these KPIs (ERP, LIMS, equipment historians, manual logs)? Options: ERP, LIMS, Equipment historians/PLC, Operator entries, Quality systems, Other
    • What would constitute a showstopper even if other metrics look good (examples: unresolved data integrity issues, operator rejection, major audit observation)?

    Scope Framing — What Must Be In, What’s Optional

    • If you could only implement three capabilities in the first release, which would they be? Options: Electronic Batch Records (EBR), Recipe/recipe management, ERP integration (material/orders), LIMS integration, Material genealogy and tracking, Real-time equipment data capture, Analytics and dashboards
    • Which modules are mandatory for initial validation and go-live at your site? Options: EBR, Recipe management, ERP/LIMS integrations, Material genealogy, Analytics (basic), Advanced analytics (ML)
    • What responsibilities should the vendor take versus your team (configuration, integrations, IQ/OQ/PQ execution, training)? Options: Vendor: full delivery including validation, Vendor config + site performs IQ/OQ, Vendor provides templates; site handles most validation, Site handles everything; vendor supplies software only
    • Are there technical constraints we must design around (ERP/LIMS versions, OPC standards, network segmentation, air-gapped areas)? Please list.
    • What cutover strategy would you prefer for lines—big bang per line, phased by module, parallel run with paper, or other? Options: Big bang per line, Phased by module, Parallel run with paper, Pilot then scale
    • What are your acceptable maintenance and downtime windows for integrations and go-live activities? Options: Night shift windows, Weekend maintenance, Planned brief outages during day, No downtime allowed

    Practical Constraints & Next Steps — What Would Stop or Accelerate This?

    • What are the top three practical barriers that could stop the project (budget, resources, validation load, operator resistance)? Options: Budget constraints, Validation complexity, IT/OT resource limits, Operator resistance, ERP/LIMS readiness, Regulatory concerns
    • What is your procurement timeline and fiscal window for a project of this type? Options: Immediate (next 30 days), Within the quarter, This fiscal year, Next fiscal year, TBD based on pilot outcomes
    • Do you have an executive sponsor already identified, and if not, who would be the logical sponsor? Options: Yes - VP Manufacturing, Yes - Head of Quality, Yes - Head of IT, No sponsor identified
    • What would a compelling pilot look like to you (scope, duration, success criteria)?
    • Assuming alignment on scope and budget, what internal approvals are needed and how long do they typically take? Options: Site-level approvals only (2–4 weeks), Corporate approvals (1–3 months), Board-level approvals (>3 months), Varies case by case
    • Finally, what would you like our next concrete step to be after this discovery—technical deep-dive, demo with your SMEs, risk/validation workshop, or a commercial outline? Options: Technical deep-dive, Hands-on demo for SMEs/operators, Validation and risk workshop, Commercial/contract outline, Pilot proposal
  2. Solution Experience

    Translate the customer’s current batch workflows into a shared future-state showing how the MES eliminates paper, reduces deviations, and delivers real-time visibility.

    Experience Meetings

    • Current-State Confirmation Workshop
    • Consequence & Metrics Quantification
    • Future-State Co-Design & Workflow Mapping
    • Solution Experience — Guided Scenario Run (Customer Context)
    • Acceptance Criteria, Validation Evidence & Next Steps
    • Obtain explicit customer confirmations on each proven consequence (validation checkpoint answers).
    • Recap Current-State Summary
    • Quantify the top operational and financial consequences of continuing current paper-based workflows.
    • Agree on the top 2–3 consequences the Solution Experience must prove will be addressed.
    • Define how improvement will be measured and validated (data sources, baseline metrics).
    • Seller: Produce a one-page Consequence Summary with quantified KPIs and estimated cost/time impact.
    • Customer: Validate KPIs and provide any missing data (e.g., FTE hours, cost per deviation).
    • Seller & Customer: Confirm which two representative scenarios will be used in the Solution Experience.
    • Re-state Current State & Consequence
    • Agree and document a single-sentence future-state that describes operational improvements in outcome terms.
    • Produce co-signed future-state workflow maps for the chosen scenarios showing eliminated paper steps and integrations.
    • List control points and explicit acceptance criteria per workflow step for validation planning.
    • Confirm pilot scope and the specific success signals that will demonstrate progress.
    • Seller: Create polished future-state workflow diagrams and mock dashboards reflecting the co-design outputs.
    • Customer: Nominate pilot production area and assign operations, QA, and IT SMEs for pilot execution.
    • Seller & Customer: Finalize the list of acceptance criteria tied to each control point.
    • Set Objectives & Validation Rules
    • Demonstrate, with live scenarios, how the MES configuration eliminates the top prioritized paper steps and reduces the targeted deviations.
    • Introductions & Objectives
    • Identify any gaps (functional, data, integration) that must be closed before pilot and assign owners.
    • Seller: Capture and deliver a 'Proof Log' listing each validated consequence with time-stamped screenshots/logs.
    • Customer: Provide validation responses (Yes/No + comments) against each tested acceptance criteria during the checkpoint.
    • Seller & Customer: Assign owners and target dates to close identified gaps prior to pilot configuration.
    • Recap Proof Points from Solution Experience
    • Produce a signed list of acceptance criteria and the exact validation evidence required for pilot acceptance.
    • Agree on owners, milestone dates, and the go/no-go decision process for pilot progression.
    • Document top risks and assigned mitigations to reduce likelihood of pilot delays.
    • Seller: Draft the formal Acceptance Criteria & Validation Evidence document and circulate for customer sign-off.
    • Customer: Nominate validation owner and provide access to validation environments/data required for IQ/OQ/PQ tests.
    • Seller & Customer: Schedule pilot build, test windows, and the formal go/no-go review on the calendar.
    • Produce a single-sentence, agreed current-state description signed off by customer SMEs.
    • Capture a detailed process map that highlights every paper/manual touchpoint.
    • Obtain representative batch records, deviation logs, and KPI data for analysis.
    • Identify primary owners (operations, QA, IT) for subsequent workshops.
    • Customer: Share 3 representative paper batch records and last 12 months of deviation logs.
    • Seller: Produce draft current-state one-sentence and detailed process map within 3 business days.
    • Customer: Provide contact details for operations, QA, and IT SMEs for follow-up workshops.
    • Define Acceptance Criteria per KPI
    • Present Baseline KPIs & Evidence
    • One-sentence Current State
    • Define One-sentence Future State
    • Scenario 1: Operator EBR Execution
    • Co-design Future Workflow (Scenario A)
    • End-to-end Process Walkthrough
    • Map Consequences to Business Impact
    • Specify Validation Evidence & Tests
    • Proof: Deviation Prevention & Exception Handling
    • Co-design Future Workflow (Scenario B)
    • Real-time Visibility Demo
    • Stakeholder Impact Breakouts
    • Roles, Responsibilities & Timeline
    • Concrete Examples of Breaks & Deviations
    • Scenario 2: Material Genealogy & LIMS Integration
    • Systems & Interfaces Inventory
    • Risk Assessment & Mitigations
    • Prioritize Top 3 Consequences for the Experience
    • Identify Control Points, Exception Handling & Acceptance Criteria
    • Define Real-time Visibility & Reporting Needs
    • Validation Checkpoint & Forced Confirmation
    • Define Measurement Method for Improvements
  3. Solution Scope

    Define modules (EBR, recipe management, integrations, material genealogy, analytics), responsibilities, and acceptance criteria.

    Scope Configuration

    • Configure Electronic Batch Record (EBR) Templates
    • Implement Recipe Management and Version Control
    • Integrate MES with ERP for Orders and Materials
    • Integrate MES with LIMS for Test Results
    • Integrate Equipment via OPC-UA/PLC Connectors
    • Deploy Real-Time Process Data Historian
    • Deploy Material Tracking and Genealogy
    • Implement In-Process Quality Check Workflows
    • Configure Deviation and Exception Handling
    • Execute IQ/OQ/PQ Testing and Documentation
    • Train Operators on Electronic Workflows and EBR Use
    • Perform Cutover and MES Go-Live from Paper Records

    Scope Questions

    Configure Electronic Batch Record (EBR) Templates

    • How many unique EBR templates (distinct batch types / SKUs) do you expect to convert to electronic form? Options: 1-5, 6-20, 21-50, 51-200, 200+
    • Which document elements must be preserved from your paper records (e.g., step text, conditional branching, checkboxes, free-text notes)? Options: Step text and instructions, Conditional branching/decision points, Numeric entry fields, Checkboxes/signoffs, Free-text narrative, Linked attachments
    • Are there required electronic signature or ALCOA+ attributes for specific fields (e.g., witness signoff, time-stamped approvals)? Options: Yes, for many fields, Yes, for a few fields, No, not required now, Unsure – need guidance
    • Who will be the owner(s) of EBR content and acceptance criteria (e.g., manufacturing SME, QA, validation)? List names/titles or roles.
    • Do you require configurable conditional logic (branching) in EBRs based on in-process results or QC outcomes? Options: Yes, extensive branching, Yes, limited branching, No branching required, Unsure
    • What are your acceptance criteria for a completed EBR (e.g., no open fields, all signatures present, no deviations)? Please list key criteria.

    Implement Recipe Management and Version Control

    • How many active master recipes versus archived recipes do you currently maintain? Options: 1-5, 6-20, 21-100, 100+
    • Do recipes require staged version control with approval workflows (e.g., draft, QA review, approved, retired)? Options: Yes, full lifecycle, Yes, basic approval only, No formal version control, Unsure
    • Which recipe elements need parameterization (e.g., setpoints, tolerances, formula variables)? Options: Setpoints, Tolerances, Formula variables, Operator instructions, Equipment assignments
    • Will recipe execution need to enforce parameter limits and trigger exceptions automatically? Options: Yes, enforce and block, Yes, alert only, No enforcement required
    • Are there specialized recipe types (e.g., multi-batch, campaign-based, nested subrecipes) to support? Options: Multi-batch/campaign, Nested subrecipes, Single-level recipes, Other
    • Which roles are responsible for recipe creation, review, and release (titles or departments)?

    Integrate MES with ERP for Orders and Materials

    • Which ERP system(s) are in scope for integration? Options: SAP ECC/S4, Oracle ERP Cloud, Infor, Microsoft Dynamics, Custom/Legacy, Other
    • What data flows are required between MES and ERP (select all that apply)? Options: Production orders / batch release, Material master updates, Inventory consumption, Finished goods receipt, Batch disposition, Costing/variance
    • Do you require real-time order issuance from ERP to MES or scheduled batch pulls? Options: Real-time (push), Scheduled polling, Manual issuance, Hybrid
    • Are there existing middleware or enterprise service bus (ESB) platforms to use for integration (name and contact)?
    • Who owns integration testing and acceptance on the ERP side (role or team)?
    • What acceptance criteria must be met for ERP integration (e.g., timely order arrival, correct material lot mapping, reconciliation reports)?

    Integrate MES with LIMS for Test Results

    • Which LIMS product(s) are used at your site? Options: Thermo Fisher, LabVantage, STARLIMS, LabWare, Custom/Legacy, Other
    • What types of test results should flow from LIMS to MES (in-process hold points, release test results, environmental monitoring)? Options: In-process QC results, Release testing, Environmental monitoring, Microbiology results, Other
    • Should LIMS results trigger automatic pass/fail gating in MES or only be visible for operator/QA review? Options: Automatic gating (block on fail), Alert and require manual review, View-only
    • Are there sample identifiers, chain-of-custody, or lot mapping conventions we must align with? Options: Yes, standardized IDs, Site-specific conventions, No formal convention, Unsure
    • Who is the accountable owner for LIMS-MES acceptance testing and signoff?
    • What SLAs are required for receiving LIMS results into MES (e.g., within X minutes/hours) and what are acceptance thresholds?

    Integrate Equipment via OPC-UA/PLC Connectors

    • How many distinct equipment assets or PLCs need to be connected initially? Options: 1-5, 6-20, 21-50, 50+
    • What control systems/protocols are present (select all that apply)? Options: OPC-UA, OPC-DA, Modbus, PROFINET, EtherNet/IP, Custom interfaces
    • Do you require bi-directional control (setpoints from MES to PLC) or read-only data capture? Options: Bi-directional control, Read-only data capture, Mostly read-only with a few writes, Unsure
    • Are there existing mapping documents or tag dictionaries for equipment signals and setpoints? Options: Yes, complete mapping, Partial mapping, No mapping available
    • What are the acceptance criteria for equipment integration (data fidelity, latency, lost-data thresholds)?
    • Who will provide PLC/automation engineering support for connector development and on-site commissioning?

    Deploy Real-Time Process Data Historian

    • What classes of process data should the historian capture (e.g., setpoints, alarms, sampled values, continuous trends)? Options: Setpoints, Continuous sensor data, Alarms/events, Operator actions, Recipe variables
    • What data retention policy is required for process data (e.g., 1 year, 5 years, GMP-defined retention)? Options: 90 days, 1 year, 3 years, 5+ years, GMP retention policy
    • Do you need aggregated KPI or OEE dashboards built from historian data during deployment? Options: Yes, standard KPIs, Yes, custom KPIs, No dashboards required
    • Are there regulatory or audit requirements for data immutability and tamper-evidence (e.g., WORM storage)? Options: Yes, strict immutability, Basic audit trail required, No special requirements
    • What are acceptable maximum data-loss and latency thresholds for historian capture?
    • Who will own historian schema and long-term archive responsibilities?

    Deploy Material Tracking and Genealogy

    • Do you require full lot-level genealogy from raw material receipt through finished product, including intermediate pools? Options: Full lot-level genealogy, Partial lineage (critical materials only), Batch-level only, Unsure
    • How are materials identified today (barcode, RFID, manual lot numbers)? Options: Barcode/QR, RFID, Manual lot numbers, ERP-assigned IDs, Other
    • Should MES support automated material reservations and consumption or manual material picklists? Options: Automated reservation/consumption, Manual picklists, Hybrid
    • Are there quarantine or hold states in material lifecycle that must be enforced by MES? Options: Yes, strict holds, Yes, advisory only, No holds
    • What acceptance criteria define a successful genealogy trace (e.g., <5% unresolved lot links, trace time < X minutes)?
    • Which teams own lot reconciliation and investigations (QA, Warehouse, Production)?

    Implement In-Process Quality Check Workflows

    • Which in-process quality checks must be automated in MES (e.g., weight checks, pH, temperature hold points)? Options: Weight checks, pH measurement, Temperature hold points, Visual inspections, Other
    • Should failed in-process checks automatically trigger deviations, hold production, or require supervisor approval? Options: Auto-trigger deviation and hold, Trigger deviation and notify, Require manual action only, Other
    • Are sampling plans and statistical acceptance criteria defined and available for configuration? Options: Yes, documented plans, Partially documented, Not defined
    • Do you need integration with analytical devices (e.g., inline analyzers) for real-time QC data? Options: Yes, multiple devices, Yes, a few devices, No
    • Who will own signoff and release when in-process QC checks pass (operator, supervisor, QA)? Options: Operator, Supervisor, QA, Other
    • What are the acceptance criteria for workflow implementation (e.g., percentage automated, reduction in manual checks)?

    Configure Deviation and Exception Handling

    • What types of deviations must be captured (process deviations, OOS, data entry errors, operator mistakes)? Options: Process deviations, OOS results, Data entry errors, Operator procedure deviations, Other
    • Should deviation creation be automatic on certain triggers or manually initiated by users? Options: Automatic on triggers, Manual only, Both automatic and manual
    • What approval workflow and roles are required for deviation investigation and closure?
    • Do you require deviation templates, CAPA linkages, or standardized root-cause fields? Options: Deviation templates, CAPA linkage required, Standard root-cause fields, No templates
    • Are there regulatory reporting obligations from deviations that MES must support? Options: Yes, internal only, Yes, regulatory reporting, No
    • What are the acceptance criteria for deviation handling (e.g., time-to-investigate targets, closure completeness)?

    Execute IQ/OQ/PQ Testing and Documentation

    • Do you have existing URS or validation requirement documents we must align to for IQ/OQ/PQ? Options: Complete URS available, Partial URS, No URS – need template
    • Which party will author and approve IQ/OQ/PQ test scripts (vendor, client, joint)? Options: Vendor authored, Client authored, Jointly authored
    • What environments are required for validation (dev, test, staging, pre-prod, prod) and who will host them? Options: All standard environments, Dev/Test/Prod only, Client hosted, Vendor hosted, Hybrid
    • Are there site-specific regulatory expectations for validation evidence format and retention? Options: FDA/21 CFR Part 11, EMA expectations, Other local regulations, None specified
    • What timeline and milestone acceptance gates are required for PQ signoff?
    • Who will be the QA approver(s) for final validation documentation and release?
  4. Mutual Commit

    Finalize commercial terms, acceptance criteria, validation obligations, timelines, and governance for go/no-go decisions.

    Agreement Modules

    • Non-Disclosure Agreement (NDA)
    • Master Services Agreement (MSA)
    • Statement of Work (SOW)
    • Order Form / Commercial Terms
    • Validation Responsibilities & Acceptance Criteria
    • IQ/OQ/PQ Protocols & Sign-off
    • Project Timeline & Milestones
    • Governance & Go/No-Go Decision Rights
    • Change Control & Change Order Agreement
    • Integration & Interface Responsibility Matrix
    • Data Migration & Cutover Acceptance Plan
    • Training & Operator Readiness Commitment
    • Support, Maintenance & Service Levels (SLA)
    • Data Processing Agreement (DPA) & Security Controls
    • Regulatory Compliance Attestation
    • IP, Source Code Escrow & Licensing Terms
  5. Deployment

    Operationalize rollout with readiness checks, enablement, and validation for GMP compliance.

    1. Pre-Deployment Readiness

      Confirm environments, data migration plan, access, validation strategy, and risk controls are ready for execution.

      Readiness Questions

      Quick Check: Where Are We Starting From?

      • To get us warmed up—what is your job title and primary responsibility for manufacturing operations at this site? Options: VP of Manufacturing, Manufacturing IT Director, Head of Operations, Site Manager, Quality/Compliance Lead, Other
      • How many production suites and simultaneous batches does your facility typically run on a given day? Options: 1–2, 3–5, 6–10, More than 10
      • Which product types does this site produce (select all that apply)? Options: Small molecule drug substance, Biologic drug substance, Drug product (sterile), Drug product (non-sterile), Clinical batches/CDMO work, Other
      • How would you describe the current state of your batch records and production visibility? Options: Paper-first with ad-hoc electronic data, Hybrid (some EBR, mostly paper), Mostly electronic but gaps remain, Fully electronic MES in some lines only, No visibility in real time
      • What’s the single thing about your current setup that you’d most like us to understand before we go further?

      Are We Comfortable Letting Paper Decide Quality?

      • How strongly do you believe paper-based batch records are an acceptable long-term risk for a GMP operation? Options: We accept it (for now), Concerned but managing, Clearly a risk we must remove, Unsure
      • When paper records cause transcription or documentation errors, what typically happens next—and how long does resolution take?
      • How often do paper-related errors trigger formal deviations, CAPAs, or regulatory observations at this site? Options: Weekly, Monthly, Quarterly, Rarely, Not tracked
      • If we moved to an electronic batch record, what is the one worry about that change that keeps you up at night?
      • What would it feel like operationally and emotionally if you no longer had to wait hours for batch reviews because everything was electronic and visible in real time?

      What’s Breaking Down on a Typical Shift?

      • Which parts of a standard batch execution most frequently cause delays, rework, or investigations? Options: Manual transcription, Material identification/line clearance, In-process testing handoffs, Equipment downtime, Deviation handling, Other
      • Can you walk me through a recent shift where things went poorly—what happened, who noticed it first, and how was it resolved?
      • How often do operators need to intervene manually in automated steps because of missing data or unclear instructions? Options: Very often, Often, Occasionally, Rarely
      • Which specific error types cause the most regulatory exposure (e.g., wrong component, missed temperature hold, incorrect weight entry)? Options: Component mix-ups, Missed process steps, Incorrect data entry, Out-of-spec process parameters, Unrecorded deviations
      • When these failures occur, what downstream impacts do you see most—release delays, stability risks, regulatory letters, or rework costs? Options: Release delays, Stability/testing failures, Regulatory findings, Extra labor/rework, Customer complaints, Other

      Who Holds the Keys—and the Pain?

      • Who must sign off on batch records, deviations, and final release at your site—and who typically delays those approvals?
      • Which teams do we need in the room for change decisions (select all that apply)? Options: Operations/Production, Quality/Compliance, Manufacturing IT, Engineering/Automation, Supply Chain/Materials, Regulatory Affairs, External CDMO/customer
      • How empowered are operators to deviate from paperwork directions when conditions change, and how is that authority documented? Options: Fully empowered with protocols, Limited empowerment with supervisor approval, No empowerment—must stop work, Ad hoc and inconsistent
      • Who is the internal owner for validation and sign-off on new systems (title/role), and what is their biggest constraint?
      • Tell me about a time a stakeholder vetoed a system change—what were their concerns and how were they addressed (or not)?

      Show Me the Evidence: Compliance & Validation Worries

      • If I asked your Quality Head whether they view MES adoption as a compliance enabler or a validation risk, what would they say—and why? Options: Compliance enabler, Validation risk, Both/Depends, Unsure
      • What validation lifecycle documents do you currently maintain for control systems (select all that apply)? Options: URS/Requirements, IQ (Installation), OQ (Operation), PQ (Performance), Traceability Matrix, CSV/Validation Plan, None
      • How many months does a typical IQ/OQ/PQ cycle take at this site for a new system, and how often do re-qualification activities occur? Options: <3 months, 3–6 months, 6–12 months, >12 months
      • Which regulators or auditing bodies are most influential for you right now (e.g., FDA, EMA, MHRA, Internal Audits, Customers)? Options: FDA, EMA, MHRA, Internal Auditors, Big Pharma customers, Other
      • What validation documentation or evidence would make your QA team comfortable signing off on an MES go-live?

      The Integration Tightrope: Systems, Data, and Interfaces

      • If integrations were a single sentence problem, how would you describe the biggest sticking point between MES and your existing systems?
      • Which systems do you need tightly integrated to make MES useful from day one (select all that apply)? Options: ERP (e.g., SAP/Oracle), LIMS, Process historian (PI), SCADA/DCS, PLC/Equipment control, Inventory/WMS, Laboratory systems, Other
      • How mature are your existing integration interfaces—are there APIs/IDOCs/OPC servers available, or will we be building from scratch? Options: Mature APIs available, Partial interfaces needing work, Mostly custom point-to-point work, Unknown
      • Which data elements are non-negotiable to exchange in real time (e.g., lot IDs, in-process test results, material movements, equipment status)? Options: Lot IDs/Material genealogy, In-process test results, Equipment status/alarms, Recipe parameters, Operator actions/audit trail, Other
      • What integrations have caused the most pain historically—and can you describe the impact they had on a product or release?

      If This Were Perfect, What Would Change Tomorrow?

      • Imagine a future-state where MES is working exactly as needed—what are three tangible differences you would notice in the first 30 days?
      • Which success signals would make you declare the project a win internally (select up to three)? Options: Reduced deviations, Faster batch release time, Lower transcription errors, Real-time production KPIs, Auditor acceptance/no findings, Operator adoption
      • What business metric would you stake your budget approval on—what would justify the investment to your CFO? Options: Cost avoidance from deviations, Faster time-to-release, Higher throughput, Lower compliance risk, Improved OEE
      • If we delivered that ideal state but operators still resisted using it, would you consider the project successful? Why or why not? Options: Yes, process improvements justify it, No, adoption is essential, Depends on the scale of resistance, Unsure
      • What would a skeptical auditor ask about your MES in year one, and how would you like to be able to answer them?

      Constraints, Timelines, and What 'Go' Really Means

      • If someone asked when this must be in place, what is the target date or regulatory milestone driving that deadline? Options: Within 3 months, 3–6 months, 6–12 months, 12+ months, Driven by a regulatory audit date
      • What are the non-negotiable acceptance criteria for a production cutover (select all that apply)? Options: IQ/OQ/PQ signed, Zero open critical deviations, Full operator training completed, Interfaces validated, Data migration verified, Customer/regulatory approval
      • Which budget or funding constraints could block a timeline even if technical readiness is achieved? Options: Capital limits, Operational expense limits, Headcount/PM resources, Customer cost-sharing, None
      • What does a safe, reversible cutover look like to you—big-bang, phased by line, or parallel runs? Why? Options: Big-bang, Phased by line/unit, Parallel runs then switch, Pilot only
      • Who has final authorization to declare 'go' or 'no-go' for deployment, and what evidence do they require?

      Readiness to Change: People, Training, and Risk Appetite

      • If we asked your frontline operators how they feel about replacing paper with a tablet-based MES tomorrow, what would they say? Options: Excited and ready, Cautious but curious, Resistant and skeptical, Undecided
      • How do you prefer operator enablement to be delivered (select all that apply)? Options: Hands-on classroom, On-the-line shadowing, Microlearning videos, Train-the-trainer, Digital runbooks
      • What training or cultural change efforts have you tried before and what worked or failed?
      • How tolerant is your leadership for a temporary productivity dip during go-live? Options: High tolerance for short dip, Moderate tolerance with limits, Low tolerance—must maintain output, Unknown
      • What would you need from a vendor to feel confident they can carry both technical and people risk during deployment? Options: Validation artifacts, Experienced pharma references, Dedicated on-site support, Comprehensive training plan, All of the above
      • Looking at people, process, and tech—where would you place your single biggest vulnerability right now? Options: People (adoption), Process (gap to standardize), Technology (integration/IT), Regulatory/validation readiness, Other

      Next Steps That Actually Move the Needle

      • Based on what we’ve discussed, what would be the most valuable next step you’d like from us (select one)? Options: Process discovery workshop, Technical integration assessment, Validation gap analysis, Pilot on a single line, Commercial proposal
      • Who should be our single point of contact to coordinate discovery activities and scheduling?
      • What is your preferred timeline to start discovery workshops? Options: Immediately, In 2–4 weeks, In 1–3 months, Later than 3 months
      • Are there any hard constraints, upcoming audits, or customer commitments we must plan around?
      • Finally, what would success from this discovery look like to you in one sentence?
    2. Deployment Enablement

      Schedule cutover, integrations, operator training, and runbooks with clear owners, sequencing, and milestones.

    3. Validation Checklist

      Execute IQ/OQ/PQ, traceability and data integrity tests, and document results against acceptance criteria.

      Validation Questions

      Getting Comfortable — Tell Me About Your Shop Floor

      • Start simple: which production area or product family should we focus this conversation on? Options: Drug substance (API), Drug product (formulation/packaging), Clinical trial batches, Contract manufacturing (CDMO) line, Other / multiple
      • How would you describe the typical batch size and cadence for that area (help us picture the day-to-day)? Options: Small batches / frequent changeover, Medium batches / steady cadence, Large batches / infrequent runs, Highly variable / campaign-based
      • Who currently records production steps and where do those records live right now? Options: Operators on paper, Operators on spreadsheets, Local MES / legacy system, Mix of paper and systems, Other
      • Roughly how many operators, supervisors, and QA reviewers are directly involved in producing and reviewing a single batch? Options: 1–3, 4–6, 7–10, 10+
      • How long has this facility relied primarily on paper batch records for the areas you just described? Options: Less than 1 year, 1–3 years, 3–7 years, 7+ years

      Are You Comfortable Accepting Manual Review as Normal?

      • When a batch is reviewed manually, what percentage of batches require clarifications, corrections, or deviations before QA signs off? Options: <10%, 10–25%, 26–50%, 51–75%, 75%+
      • Describe the most recent deviation that originated from transcription or paperwork—what happened and how did it impact the release decision?
      • How many person-hours does your team spend per batch on document reconciliation and manual data review? Options: <2 hours, 2–6 hours, 6–12 hours, 12–24 hours, 24+ hours
      • Which feelings best describe how operators and reviewers react to the current paperwork burden? Options: Frustration, Resignation, Pride (doing it carefully), Anxiety about audits, Indifference
      • How often do transcription errors trigger investigations or CAPAs in a typical year? Options: Never, 1–2, 3–5, 6–10, 10+

      Where Paper Is Quietly Increasing Your Risk (and Cost)

      • If we stopped paper today, what single regulatory risk would you expect to shrink the fastest? Options: Transcription errors, Incomplete traceability, Inadequate change control records, Delayed responses to inspections, Other
      • How many regulatory inspections (FDA/EMA/other) has this site had in the last 3 years and were there findings specifically tied to batch records? Options: None, 1, 2, 3+, Prefer not to say
      • Quantify the business impact: over the last 12 months, how many batches were delayed or rejected due to documentation issues? Options: None, 1–3, 4–10, 11–25, 25+
      • When deviations occur because of paperwork, what downstream costs have you seen (choose all that apply)? Options: Rework, Extended release time, Regulatory reporting, Product hold/recall risk, Increased QC testing, Other
      • Tell me about a near-miss where lack of real-time data visibility made a difference—what went wrong and how long did it take to resolve?

      Who Really Holds the Keys (and Who Will Block Change)?

      • If you proposed an MES to eliminate paper, who would need to sign off for budget and execution? Options: VP Manufacturing, Head of Quality/QA, CFO/Finance, IT Director, Operations Head, Other
      • Which stakeholder is most likely to say “not now” and why (operational disruption, validation effort, cost, culture)? Options: Operations disruption, Validation complexity, Budget constraints, IT capacity, Operator resistance, Other
      • How would you rate internal appetite for change on a scale from cautious to urgent? Options: Highly cautious, Cautious, Open but pragmatic, Eager, Urgent — must act
      • Who will own acceptance criteria and release decisions for a new MES (name roles/functions)? Options: QA/Release, Manufacturing/Operations, Validation/Compliance, IT/Integration, Executive sponsor
      • What past digital projects succeeded or failed here, and what did you learn about stakeholder alignment from them?

      What Would ‘No More Paper’ Really Feel Like?

      • Imagine a day without paper batch records—what three immediate changes would operators, supervisors, and QA notice first?
      • Which KPI improvements would make leadership call the project a success within 6–12 months? Options: Faster batch release time, Fewer deviations per 100 batches, Reduced review hours, Improved OEE, Reduced inspection findings
      • How much faster would you want batch release to be (target improvement)? Options: No change needed, 10–25%, 26–50%, 50%+
      • What operator behaviors need to change for an electronic batch record to work long-term (training, procedure updates, accountability)? Options: New operator training, Updated SOPs, Line-level champions, Digital checklists, Incentives/performance metrics
      • If success required a cultural shift, how would you measure whether the culture is actually changing?

      Integration Reality Check — Will Your Systems Cooperate?

      • What core systems must the MES integrate with for this scope to work (select all that apply)? Options: ERP (SAP/Oracle/etc.), LIMS, DCS/PLC/SCADA, Inventory/WMS, Historian / OSI PI, Other
      • For each system you selected, how mature are the existing interfaces (APIs, IDoc/EDI, OPC, custom adapters)? Options: Well-documented APIs ready, Basic connectors available, Custom integration required, No clear integration path, Unsure
      • How much of your equipment currently supports automated data capture (serial/parallel integration, OPC-UA, direct I/O)? Options: Most equipment, About half, Few pieces, None
      • Which integrations have caused the most delays in prior projects—ERP mapping, LIMS test flows, or equipment connectivity? Options: ERP mapping, LIMS workflow, Equipment connectivity, Other
      • If we needed to run a short integration pilot, which interface would you prioritize to demonstrate value? Options: ERP order/material sync, LIMS result flow, Equipment/data historian capture, Recipe download to PLC, Material genealogy

      Validation & Compliance — How Tight Is Your Risk Window?

      • When you hear ‘IQ/OQ/PQ’, what’s the biggest internal hurdle that comes to mind? Options: Document burden, Resource availability, Regulatory scrutiny, Test data readiness, Time to execute
      • Who is responsible for validation activities at your site and how many full-time-equivalent (FTE) validation resources are available? Options: Dedicated validation team (3+ FTE), Small validation team (1–2 FTE), Shared QA/validation resources, No internal validation resources
      • What validation artifacts would you expect the MES vendor to provide out of the box (select all that apply)? Options: Functional spec / URS mapping, IQ/OQ test scripts, Traceability matrix, CSV/CSV policy guidance, Validation-ready test data, Other
      • How strict are your change control and revalidation thresholds—would a configuration change require full revalidation or limited testing? Options: Full revalidation for many changes, Limited testing for config-only changes, Case-by-case, Unsure
      • Describe a past validation effort that went smoothly—what made it work, and how long did it take from IQ to PQ?

      What Will Success Look Like — And Who Will Celebrate It?

      • List the top three success signals that would make this program undeniable to your executive team.
      • Which metric would you include in a board-level one-page to justify the investment? Options: Days saved in release, Reduction in deviations, FTE hours reclaimed, Financial savings / avoided costs, Inspection risk reduced
      • Who will be the public champion for this in a year (role, not person)? Options: VP Manufacturing, Head of QA, CIO/IT Director, Operations Director, Other
      • How would you like validation acceptance criteria documented so it's clear for operations, QA, and auditors? Options: Formal acceptance matrix, Live dashboard with targets, Checklist by batch family, Written SOP with examples, Other
      • If we could guarantee one outcome within 12 months, which single outcome would move you to commit? Options: Reduced deviations, Faster release, Audit-ready traceability, Operator adoption, Cost savings

      Small Tests Before Big Bets — What’s the Least We Could Do?

      • Would you be open to a short pilot (1–2 lines or 1 product family) to validate assumptions before enterprise-wide rollout? Options: Yes — pilot immediately, Yes — pilot in a few months, Maybe — need more info, Not at this time
      • If a pilot, what scope would best prove ROI quickly (choose one)? Options: Paperless EBR on 1 line, Integration with ERP for material sync, Automated data capture from 1 critical instrument, Recipe management for 1 process
      • What timeline feels realistic for a pilot to move to a validated production pilot (IQ/OQ/PQ milestones)? Options: <3 months, 3–6 months, 6–9 months, 9–12 months, 12+ months
      • What are the non-negotiable requirements for a pilot to be considered successful by your team?
      • Who should be involved in a pilot steering group to ensure fast decisions and cross-functional alignment? Options: Operations, QA/Validation, IT/Integration, Supply Chain/ERP, Executive sponsor
  6. Success

    Review outcomes against success signals, capture lessons learned, and maintain a shared channel for issues and enhancements.

    Success Reviews

    • Executive Success Review
    • Operational Performance Review
    • Validation Closeout & Compliance Review
    • Lessons Learned & Continuous Improvement Workshop
    • Governance & Issues/Enhancements Forum (Recurring)

    Issues & Enhancements

    • Collect and document cross-functional lessons learned with clear evidence and examples.
    • Create a short weekly ops KPI snapshot to track progress between meetings.
    • Opening & Purpose
    • Ensure all validation acceptance criteria are evidenced and documented or assigned for remediation.
    • Secure QA agreement on release-to-GMP operations or conditional release with defined CAPAs.
    • Establish ownership and timeline for closure of all open validation items.
    • Publish the validation summary dossier with links to IQ/OQ/PQ evidence and audit trail exports.
    • Create CAPA records for each conditional or failed item with owners and due dates.
    • Update the Validation Master Plan and change control registry to reflect final status.
    • Schedule final QA sign-off meeting once remediation evidence is available.
    • Create a prioritized enhancement backlog in the shared channel with owners and acceptance criteria.
    • Assign owners and target release windows for the top-priority improvements.
    • Workshop Framing & Rules
    • Welcome & Objectives
    • Produce a prioritized enhancement backlog tied to operational impact and effort estimates.
    • Schedule focused implementation sprints or change windows for top 3 enhancements.
    • Document lessons learned and update SOPs/training materials where process gaps were identified.
    • Define metrics to track the effectiveness of implemented enhancements.
    • Review Open Issues Log
    • Triage and assign resolution paths for all open issues in the shared channel.
    • Approve release scope that balances operational benefit with validation/regulatory risk.
    • Maintain a transparent, auditable record of decisions and owners for changes.
    • Update issue tracker with decisions, owners, and target completion dates after each meeting.
    • Publish release candidate scope and validation plan at least X weeks prior to deployment.
    • Route approved changes through change control and schedule IQ/OQ/PQ where required.
    • Maintain and moderate the shared issues/enhancements channel and ensure traceability.
    • Confirm whether implemented solution meets the defined success signals and quantitative targets.
    • Obtain executive approval for recommended remediation or next-phase investments.
    • Align on governance, reporting cadence, and owner for ongoing issues/enhancements.
    • Publish final executive success report with attached KPI evidence and recommended actions.
    • Assign executive sponsor and owners for any approved remediation or expansion investments.
    • Schedule recurring executive checkpoint cadence (monthly/quarterly) for continued oversight.
    • Prepare regulatory support package (validation summary, data integrity evidence) for audits/inspectors.
    • Meeting Context & Success Signals Focus
    • Validate that daily/shift production metrics reflect the expected operational improvements.
    • Identify and assign owners for immediate fixes that reduce deviations and rework.
    • Capture training or procedural gaps and schedule targeted interventions.
    • Log all operational incidents and improvement requests to the shared issues channel with priority tags.
    • Assign owners and due dates for top 5 operational quick wins.
    • Schedule refresher operator training for workflows with recurring deviations.
    • What Went Well
    • Recap of Success Signals
    • Change Request Review
    • Acceptance Criteria Mapping
    • Production Metrics Review
    • IQ/OQ/PQ Evidence Review
    • Release Planning & Sequencing
    • What Didn't Go Well
    • Deviations & Exceptions Trends
    • KPI & Outcomes Dashboard
    • Regulatory & QA Impact Assessment
    • Validation & Compliance Summary
    • Traceability & Data Integrity Checks
    • Operator & Supervisor Feedback
    • Root Cause Breakouts
    • Decisions & Owner Commitments
    • Integration & System Stability Review
    • Operational & User Feedback
    • Prioritize Enhancements (Impact vs Effort)
    • Remediation & CAPA Plan
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.